Poll shows military veterans back cannabis legalization

Veterans poll adds a loaded constituency to the legalization debate

Marijuana Moment reported on Oct. 20, 2026, that a poll shows military veterans support legalizing cannabis. The item led the outlet's weekday newsletter.

That's the verified core. Veterans are among the most politically courted voters in U.S. cannabis policy, and a poll in their name lands differently than a general-population survey.

The newsletter excerpt leaves the key numbers out

The signal we reviewed didn't include the pollster, sample size, margin of error or topline percentage. We won't guess at them. Big caveat.

Those details decide how much weight the result deserves. A poll of veterans can mean current service members, retirees, VA patients or all former troops, and each group answers differently. Until the underlying release is public, treat the headline as direction. It isn't measurement.

CannIntel will update this story once the poll's methodology is confirmed.

Why veterans polling moves Capitol Hill

Veterans' views carry outsized weight because federal policy governs their care directly. The Department of Veterans Affairs operates under federal law, where cannabis remains a controlled substance. VA's long-standing guidance has barred its clinicians from recommending medical cannabis or helping patients enroll in state programs.

So a veteran in a legal state can hold a state medical card and still get no recommendation from the doctor who manages the rest of their care. That gap is the argument advocates keep making to lawmakers. A poll showing veteran support gives them a fresh data point, even without the precise figures.

Politically, it's an easy talking point. Few members of Congress want to be seen as standing between a veteran and relief.

Same newsletter, three other threads worth tracking

The Oct. 20 newsletter also flagged hemp, litigation and advocacy stories that run alongside the veterans poll. According to Marijuana Moment's description, the issue covered:

• A hemp company sending THC drinks to congressional lawmakers.
• A NORML brief filed in a lawsuit involving the marijuana business.
• An op-ed on hemp from the Marijuana Policy Project (MPP).

The drink stunt is the tell. Hemp-derived THC beverages have become a lobbying fight in their own right, and sending product to Capitol offices is a blunt way to put it on lawmakers' desks. We haven't confirmed the company, the products or the lawsuit named in the NORML brief from the excerpt alone.

The view from Latin America: why U.S. polling echoes south

Washington's cannabis politics shape export strategy in Colombia, Uruguay, Brazil and Mexico, even when no product crosses the border. Each country took a different route. Uruguay legalized adult use in 2013. Colombia built a medical framework under Law 1787 in 2016. Brazil's regulator, ANVISA, allows patient access to certain products under its own rules, while Mexico's Supreme Court has found prohibition unconstitutional without Congress finishing a full regulatory scheme.

For producers in those markets, the U.S. is the prize and the wall, because while cannabis stays federally controlled there's no lawful path for Latin American flower into U.S. commerce. Every shift in American opinion, including among veteranos and veteranos de guerra who gravitate toward medical use, nudges that wall's timeline.

The math is straightforward. Larger domestic majorities make federal change likelier, and federal change is what exporters in Bogotá and Montevideo are waiting on. Still waiting. For background on how this polling fits the broader story, see the CannIntel topic hub on veterans and cannabis legalization polling.

What to watch next

The next signal is the poll's full release, which will show whether veteran support is broad or narrow. Watch for the sponsor, the sample and any split between medical and adult-use legalization. Those splits matter more to legislators than a single headline number.

Also watch whether veterans' groups or sponsors of VA-related cannabis bills cite the result in coming weeks. If they do, the poll becomes a lobbying tool. If not, it stays a one-day news item.